CN104306988B - Uses of miR-431 in preparation of muscular disease treatment medicines - Google Patents
Uses of miR-431 in preparation of muscular disease treatment medicines Download PDFInfo
- Publication number
- CN104306988B CN104306988B CN201410496029.3A CN201410496029A CN104306988B CN 104306988 B CN104306988 B CN 104306988B CN 201410496029 A CN201410496029 A CN 201410496029A CN 104306988 B CN104306988 B CN 104306988B
- Authority
- CN
- China
- Prior art keywords
- mir
- muscle
- cell
- muscular dystrophy
- mice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a use of miR-431 in the preparation of muscular disease treatment medicines, concretely relates to functions of miR-431 in skeletal muscle stem cells and muscular disease treatment, especially relates to a use of miR-431 in muscle injuries and muscular dystrophy, and also relates to a use of miR-431 in the preparation of skeletal muscle stem cell activation, proliferation and differentiation promotion medicines, and an miR-431-containing medicinal composition for treating muscular diseases.
Description
Technical field
The present invention relates to medical domain, in particular to miR-431 in treatment muscle disease, particularly muscle injury and
Purposes in muscular dystrophy.
Background technology
Skeletal muscle plays very important effect in the vital movement of organism.It not only plays motion and supports work(
Can, it is an important metabolic organ simultaneously.The metabolism in skeletal muscle of the material such as sugar that body is absorbed and lipid produces energy
Amount, this plays very important effect to the steady statue maintaining whole body.Many diseases such as tumor, HIV, chronic
The patients such as the heart failure symptom that late skeletal muscle being accompanied by gradually decrease more.Additionally, skeletal muscle or important endocrine organ
Official, secretes some regulatory factors, such as muscle mass (Myostatin), IL-6, IL-8, IL-15 and FGF21 etc..These regulation and control
The factor also participates in other physiology and pathological process [1] in addition to adjusting the growth promoter of skeletal muscle itself.
Satellite cell is the main stem cell of skeletal muscle, and satellite cell is in the list between muscle fiber sarolemma and basement membrane
Nucleuss [2].Satellite cell expresses a series of molecular marked compounds, such as Pax7, M- cadherin, c-Met, MNF, NCAM and
VCAM-1 etc..It is different in the quantity of the different phase satellite cell of different plant species and growth.Newborn mice centre halfback astrocyte
Quantity account for whole flesh core 30% about grow up after, the ratio of satellite cell is reduced to 4%, to after old age, mouse satellite cell
Ratio drop to 2% about.
One marked feature of skeletal muscle tissue can be regenerated after injury, and satellite cell regenerates in Skeletal muscle injury
During play critical function.Satellite cell is in quiescent condition in normal state, when by environmental stimuli such as damage or fortune
In the case of dynamic, the satellite cell being in quiescent condition is activated, and the satellite cell of activation, through propagation, differentiation, merges and formed
New core, in central skeletal muscle fiber, has part cell to maintain stablizing of skeletal muscle satellite cell storehouse by self renewal simultaneously
Property.This process is that hight coordinate is unified [3,4].At nominal conditions, skeletal muscle passes through the new skeleton being formed of injury regeneration
The form of flesh and function do not have difference with the skeletal muscle not having to damage.A lot of myopathies the later stage deteriorate be because satellite cell self
Renewal is suppressed caused by leading to the activation of satellite cell exhaustion or satellite cell, propagation to be suppressed.So research skeleton
Muscle satellite cell is bred, and the mechanism of differentiation and self renewal is significant for treatment skeletal muscle disease.
The non-coding microRNA that microRNA (also writing miRNA or miR) has regulation activity as a class is (usual
18 to 25nt), the growth of the various histoorgan of wide participation is occurred with disease.MiRNA participates in the positive evidence of skeletal development
The skeletal development coming from mice after skeletal muscle tissue conditionality knocks out Dicer gene occurs extremely, including skeleton
Flesh etc. reduces, muscle fiber paramophia.The albumen of Dicer gene code is necessary nucleic acid in the miRNA maturation course of processing
Restriction endonuclease, this shows that miRNA plays a significant role during skeletal development.Now it has been reported that there being many miRNA to participate in
The process [5-8] of Skeletal muscle injury regeneration.First is reported in occur that expression changes during injury repairing is miR-181,
Significantly raise [9] in the final stage miR-181 expression of injury regeneration.MiR-351 is in the early expression amount of CTX injury regeneration
It is instantly increased, miR-351 passes through the propagation [10] suppressing cell cycle inhibitors E2F3 to promote satellite cell.MiR-206 exists
After CTX damages, expression significantly raises, this prompting miR-206 function, this and miR-206 in Skeletal muscle injury regeneration
In knock out mice, Skeletal muscle injury regeneration function is badly damaged consistent [11].The expression of miR-206 raises and can press down
The expression of many genes processed, including Pax7, Notch3, IGFBP5 [11] and HMGB3 [12], and all these gene all presses down
Atomization processed.Additionally, the expression of miR-1 raises the expression [13] also contributing to suppress Pax7 in damage process.Equally
In ground, after CTX damages, miR-26a expression raises.After striking low miR-26a expression in tibialis anterior, Skeletal muscle injury
The process of regeneration slows down [14].In identical model, miR-125b expression after CTX damage raises, miR-125b downstream
Target gene IMA-IGF2BP3-001 (IGF-2) expression increase [15].IGF-2 can regulate and control myogenic differentiation process and suppress
Injury regeneration process [15] afterwards.Additionally, during regeneration, the increase of miR-133 expression is to prevent satellite cell from becoming brown fat
Fat cell [16].During increasing miRNA participates in Skeletal muscle injury regeneration, ectogenic miRNA intervenes damage
Regenerative process is probably a direction of future therapeutic muscle disease.
Muscle mass (also referred to as growth and differentiation tactor-8, growth and differentiation factor-8,
GDF8) it is TGF-β family member [17].Myostatin gene knock-out mice whole body skeletal muscle significantly increases.Meanwhile, multiple kinds
The animal (for example, double flesh cattle [18-19], dog [20], sheep [21] and people [22] etc.) belonging to, because myostatin gene is natural
After mutation, all the phenotype similar with myostatin gene knock-out mice skeletal muscle in skeletal muscle.Therefore, muscle mass
It has been regarded as since finding from 1997 controlling the negative regulatory factor of muscle development, and cause extensive concern.Muscle suppresses
Effect in plain skeletal development after birth is mainly reflected in two aspects:First, muscle mass is to normal bone after birth
The regulation and control of bone flesh growth promoter;Second, in the case of various muscle injurys, stimulation or myopathy, muscle mass damages to skeletal muscle
The impact that wound is repaired.Although a lot of evidences show, sarcoplast and satellite cell are that the target that muscle mass acts in vivo is thin
Born of the same parents, but other cell is likely to be regulated and controled by muscle mass.After overexpression muscle mass in adult mice, can induce into
Year, cachexia (cachexia) in mice, and whole body skeletal muscle and fatty tissue substantially reduce.These animals skeletal muscles reduce
Degree and speed are difficult to only be explained with muscle mass suppression satellite cell.Therefore, muscle mass is likely to directly
Act on myotube.There are some researches show now, muscle mass can suppress the albumen of the myotube being broken up by C2C12 to synthesize.This
Outward, muscle mass makes fatty tissue quick depletion, and this prompting muscle mass has direct effect to fatty tissue.In HIV sense
Under the disease event such as dye, cachexia and chronic heart failure, skeleton muscle size reduces in a large number, simultaneously the expression of muscle mass
Raise.Show that muscle mass may participate in the morbidity of these myopathies or the Skeletal muscle injury that causes of these diseases was repaired
Journey.Therefore, intervene the expression of muscle mass or suppress its activity, may have and can alleviate the skeleton human body being caused by these diseases
Long-pending decline and the forfeiture of function, (sarcopenia), muscular dystrophy (dystrophy) etc. are levied in such as old skeletal muscle decay.
Muscle disease (muscular disorders) typically refers to skeletal muscle disease.Muscular dystrophy is one group and is primary in
The heredopathia of muscular tissue.The skeletal muscle atrophy that clinical signs increase for progressive is false with powerless, tendon reflex disappearance, muscle
Loose.Position is involved according to patient muscle's atrophy and can be divided into polytype:Duchenne/Becker type muscular dystrophy (DMD/
BMD), face shoulder-upper arm type muscular dystrophy, limb-girdle type muscular dystrophy, quadriceps femoris type muscular dystrophy, distal type myotrophy be not
Good, ocular myopathy type muscular dystrophy, eye muscle-pharynx flesh type muscular dystrophy.DMD type muscular dystrophy is most common
A class progressive muscular dystrophy.Prevalence is 3.3/10 ten thousand, accounts for the 20-30/10 ten thousand of birth boy baby, is X- linked recessive
Heredity.Mainly boy's morbidity, women is the carrier of Disease-causing gene.Usual 5 years old about morbidity.The flesh of being by property of amyotrophy
Meat disease, poor prognosis, typically lethal with myocardial function exhaustion or dyspnea etc. when 20-30 year.Currently for this disease, cure
Educational circles there is no effective therapy.Mdx mice is dystrophin (dystrophin) genetic flaw Mus, is that research skeletal muscle is done
Cell-stimulating, the most frequently used model of propagation, differentiation regulatory mechanism and Skeletal muscle injury-regeneration mechanism.
Initial research reports that the sarcoplast of In vitro culture can make dystrophin recover weight in Mdx mice
New expression, this has evoked the very big enthusiasm [23] to the treatment of clinical muscular dystrophy.It is true that autoplastic by satellite cell
The sarcoplast developing in clinical practice in the reparation of cardiac muscle, also all some positive result simultaneously.But, have
Several big obstacles have slowed down to the research based on satellite cells for treatment myotrophy disorders.Autoplastic satellite cell is still not
Dystrophin can be expressed, only the satellite cell using heteroplastic transplantation compensates the myotrophy of disappearance in DMD patient
Not dystrophin.Therefore, there is following problem, be the immunologic rejection of host first, next to that depositing after transplanting satellite cell
Work, self renewal and migration are all poor.It is the theoretical basiss of future therapeutic muscular dystrophy to the research of as above problem, have
Potential applicability in clinical practice well.
Content of the invention
In view of above technical problem, according to the disclosure some embodiment there is provided miR-431 is in preparation treatment muscle
Purposes in the medicine of disease.
In the disclosure, muscle disease refers to skeletal muscle disease, and it is selected from muscle injury and muscular dystrophy.Real at some
Apply in mode, described muscle injury is acute muscle injury.In some embodiments, described muscular dystrophy is selected from:
Duchenne/Becker type muscular dystrophy, face shoulder-upper arm type muscular dystrophy, limb-girdle type muscular dystrophy, quadriceps femoris type flesh
Malnutrition, distal muscular dystrophy, ocular myopathy type muscular dystrophy and eye muscle-pharynx flesh type myotrophy are not
Good.In some specific embodiments, muscular dystrophy is Duchenne/Becker type muscular dystrophy.
In the disclosure, the nucleotide sequence of described miR-431 such as UGUCUUGCAGGCCGUCAUGCA (SEQ ID
No.1, Genbank no.MIMAT0001418) shown in.
In some embodiments, described treatment is selected from following one or more:Promote myoblastic differentiation, promotion
Skeletal muscle injury regenerates, improves pathology and physiological phenotype.
In some embodiments, the myoblastic differentiation of described promotion refers to improve myogenin and/or myosin weight
The expression of chain.
In some embodiments, described promote Skeletal muscle injury regeneration refer to promote the activation of satellite cell, propagation and
Differentiation.
In some embodiments, described improve pathology and physiological phenotype refers to selected from following one or more:Reduce
Serum creatine kinase level, improvement fatigue and raising muscle fiber tension force.
According to the disclosure other embodiment there is provided miR-431 preparation promote muscle stem cell activation, propagation
And the purposes in the medicine of differentiation.
According to other embodiments of the disclosure, provide a kind of pharmaceutical composition for treating muscle disease, its bag
MiR-431 containing therapeutically effective amount.Described muscle disease is selected from muscle injury and muscular dystrophy.In some embodiments,
Described muscle injury is acute muscle injury.In some embodiments, described muscular dystrophy is selected from:Duchenne/
Becker type muscular dystrophy, face shoulder-upper arm type muscular dystrophy, limb-girdle type muscular dystrophy, quadriceps femoris type muscular dystrophy,
Distal muscular dystrophy, ocular myopathy type muscular dystrophy and eye muscle-pharynx flesh type muscular dystrophy.In some tools
In the embodiment of body, muscular dystrophy is Duchenne/Becker type muscular dystrophy.
In some embodiments, described pharmaceutical composition is prepared to be adapted for the form of microinjection or is suitable to turn
The form of dye.
In some specific embodiments, described pharmaceutical composition is in vitro administration:By miR-431 or being capable of table
The carrier reaching miR-431 imports or transfection of mammalian is autologous or variant cell in vitro, after vitro cell expansion, the defeated time food in one's mouth
Newborn animal body.In other specific embodiments, described pharmaceutical composition is internal administration:MiR-431 or can
The carrier of expression miR-431 is introduced directly in mammal body.This carrier can be virus type or non-viral, even naked
DNA or RNA.
Described mammal is selected from the mankind, mice, Canis familiaris L., rabbit, cattle or monkey;The preferably mankind or mice;The most preferably mankind.
As needed, pharmaceutical composition also includes pharmaceutical acceptable carrier, and it includes but is not limited to:Diluent, buffer agent, suspension
Agent, Emulsion, granule, encapsulation agents, excipient, filler, binding agent, spray, cutaneous permeable agent, wetting agent, disintegrating agent, suction
Receive accelerator, surfactant, coloring agent, correctivess or absorption carrier.
Brief description
Fig. 1 is shown in miR-431 in microarray and knocks out the expression in Mus and wild-type mice in myostatin gene.
In Fig. 2 display real-time quantitative PCR checking microarray, miR-431 knocks out Mus in myostatin gene and wild type is little
The result of the expression in Mus.
Fig. 3 shows expression in the satellite cell that myostatin gene knocks out Mus and wild-type mice for the miR-431.
It is thin that Fig. 4 display processes C2C12 using the muscle mass of restructuring with different dosage (0,0.5,1,1.5 μ g/ml)
The expression of miR-431 after born of the same parents.
Fig. 5 show using restructuring muscle mass with 1 μ g/ml dosage process respectively C2C12 cell different time (12,
24th, 36,48h) miR-431 afterwards expression.
Fig. 6 shows that to be jointly processed by C2C12 using muscle mass and its inhibitor follicostatin (Follistatin) thin
The expression of born of the same parents miR-431 after 24 hours.
Fig. 7 show inhibitor PD98059 and the muscle mass of Mek be jointly processed by C2C12 cell after p-Erk in albumen water
Flat expression.
Fig. 8 shows that the inhibitor PD98059 of Mek and muscle mass are jointly processed by the table of miR-431 after C2C12 cell
Reach.
Fig. 9 shows that muscle mass processes C2C12 (DN-Ras) cell and the matched group C2C12 of the mutation of Ras negativity simultaneously
After cell, p-Erk, p-Mek are in the expression of protein level.
Figure 10 shows that muscle mass processes C2C12 (DN-Ras) cell and the matched group C2C12 of the mutation of Ras negativity simultaneously
The expression of miR-431 after cell.
Figure 11 shows gene expression abundance in the different tissues of adult mice for the miR-431.
Figure 12 shows expression change in C2C12 cell differentiation procedure for the miR-431.
Figure 13 shows expression change in skeletal muscle satellite cell atomization for the miR-431.
Myogenin after Figure 14 display C2C12 cell differentiation matched group and stable transfection miR-431 after 24 hours (Myognin,
MyoG immunofluorescent staining result).
Myoglobulin heavy chain after Figure 15 display C2C12 cell differentiation matched group and stable transfection miR-431 after 36 hours
(MHC) immunofluorescent staining result.
After Figure 16 display C2C12 cell differentiation matched group and stable transfection miR-431 after 24 hours, myogenin is in transcription water
Flat expression.
After Figure 17 display C2C12 cell differentiation matched group and stable transfection miR-431 after 24 hours, myogenin is in albumen water
Flat expression.
Myosin after Figure 18 and Figure 19 display C2C12 cell differentiation matched group and stable transfection miR-431 after 36 hours
Heavy chain is in the expression of transcriptional level and protein level.
Flesh (TA flesh) cross section HE dyeing before Figure 20 display CTX induction 8-10 week 7 days ossa tibiale posteriuses of mouse muscle injury regeneration
Result.
After Figure 21 display muscle injury, the crosscutting superior facial nucleus of 7 days tibialis anterior is in central muscle fiber number ration statisticses.
(green) immunity of MyoD after Figure 22 display miR-431 transgenic mice and wild-type mice reason after CTX damages 1 day
Fluorescence staining result, DAPI dyeing (red) positioning nucleus.
Figure 23 shows MyoD positive cell quantity statistical result, more than 10 visuals field of every group of statistics.
Figure 24 display miR-431 transgenic mice and wild-type mice Pax7 and MyoD protein level after CTX damages 1 day
Testing result, GAPDH is as quantitative control.
Pax7 (red) MyoD after Figure 25 display miR-431 transgenic mice and wild-type mice reason after CTX damages 3 days
(green) immunofluorescence dyeing result, DAPI dyeing (blue) positioning nucleus.
Figure 26 shows Pax7 and MyoD double positive cells quantity statistics result, more than 10 visuals field of every group of statistics.
Figure 27 display miR-431 transgenic mice and wild-type mice Pax7 and MyoD protein level after CTX damages 3 days
Testing result, GAPDH is as quantitative control.
Figure 28 and Figure 29 shows the table of miR-431 transgenic mice and wild-type mice eMHC after CTX damages 3 and 7 days
Reach the testing result of level.
Figure 30 shows and breaks up 36 hours with separating culture after satellite cell wild-type mice from miR-431 transgenic mice
The immunofluorescent staining result of MHC afterwards.
Figure 31 shows and breaks up 36 hours with separating culture after satellite cell wild-type mice from miR-431 transgenic mice
The number of MHC positive cell afterwards, the visual field that each statistics is more than 10.
Figure 32 shows and breaks up 36 hours with separating culture after satellite cell wild-type mice from miR-431 transgenic mice
The detection of the expression of MHC afterwards.
Figure 33 shows from miR-431 transgenic mice with to separate suspension culture 72 after single muscle fiber wild-type mice little
The result that Shi Houfen Pax7 (red), MyoD (green) and DAPI (blue) dye respectively.
Figure 34 display differentiation (Pax7-/MyoD+) Status satellite cell ratio.
Figure 35 A and 35B is mdx::MiR-431 (B) and mdx (A) tibialis anterior azovan blue EBD infiltration (red) area
And the immunofluorescence dyeing of Lamin (green) display cell membrane.
Figure 36 is shown as mdx::The area system that in miR-431 and mdx tibialis anterior tibialis anterior (TA), azovan blue is contaminated
Meter result.
Figure 37 shows mdx::Creatine kinase horizontal detection result in miR-431 and mdx tibialis anterior (TA) serum.
Figure 38 is shown as mdx::MiR-431 and mdx mice is run and tests movement time record result.
Figure 39 and 40 is shown as mdx::MiR-431 and mdx muscle strength testing result.
Specific embodiment
Muscle injury model described in the disclosure refers to snake venom cardiotoxin (Cardiotoxin/CTX) intramuscular injection shin
The acute muscle injury model that before bone, flesh causes.This model preferably provides muscle stem cell function after muscle injury
Process.
Muscular dystrophy model of the present invention refers to, using mdx mouse model, be widely used as DMD muscular dystrophy
Model, this model simulates human muscular's disease in gently progressive mode.
C2C12 cell is mouse muscle-forming cell system.
Embodiment 1. muscle mass passes through the expression of Ras/Raf/Mek/Erk signal path negative regulation miR-431
1. screen the miR-431 by muscle mass negative regulation
The miR-431 selecting up-regulated in myostatin gene knock-out mice skeletal muscle tissue is as candidate
MiRNA is studied to its function and oneself expression regulation and control.In 5 stages of skeletal development, miR-431 suppresses in muscle
Expression in plain gene knock-out mice is above wild-type mice (as Fig. 1).From (the purchase of myostatin gene knock-out mice
From:Nanjing model animal institute) and wild type siblings mice (littermate control of knock out mice) different developmental phases (E15.5,
4 weeks, 10 weeks, 16 weeks and 40 weeks) skeletal muscle tissue in extract total serum IgE, using miRNA chip of expression spectrum method screening and identify
The miRNA of differential expression in myostatin gene knock-out mice and wild-type mice skeletal muscle tissue.By statistical analysis,
Identify the miR-431 having differences in myostatin gene knock-out mice with the expression of wild-type mice skeletal muscle.
The result of Fig. 1 shows:MiR-431 expresses higher than wild-type mice prompting in myostatin gene knock-out mice
The expression of muscle mass negative regulation miR-431.
2. (Real-time) checking in real time
Take myostatin gene knock-out mice and wild type siblings mice different developmental phases (E15.5,4 weeks, 10 weeks,
16 weeks and 40 weeks) skeletal muscle tissue total serum IgE.
(1) reverse transcription:Following reagent is added in the PCR reaction tube of 0.2mL:
16 DEG C of reactions open hairpin structure in 30 minutes, and 42 DEG C are reacted 30 minutes, 85 DEG C of inactivators 5 minutes;
(2) real-time PCR:The real-time PCR of MicroRNA:Following reagent is added in 96 orifice plates:
The result of Fig. 2 shows:It is higher than wild-type mice that miR-431 expresses in myostatin gene knock-out mice, real
Real muscle mass negative regulator miR-431 of checking.
3. in myostatin gene knock-out mice and wild-type mice satellite cell miR-431 expression detection
(1) the disconnected neck of 3-4 week old myostatin gene knock-out mice and wild-type mice is taken to put to death, alcohol disinfecting.From foot
Toe direction is torn skin and is taken tibialis anterior, gastrocnemiuss, quadriceps femoris respectively, avoids getting tendon as far as possible, avoids being stained with Mus as far as possible
Hair;With shears, muscle is shredded into gravel size in 35mm culture dish;(2) add 2ml Digestive system, put into incubator and digest 15 points
Clock, then dispels separating muscle tissue with pipette tips as far as possible;(3) it is placed again into incubator to digest 15 minutes, then blow again as far as possible
Dissipate, until there is no bulk tissue;(4) add in 3ml culture medium and Digestive system;(5) add the tissue of 8ml PBS dilution digestion;
(6) 40 μm of filtrations;(7) 1500rpm centrifugation 10min;(8) abandon the proliferated culture medium re-suspended cell of supernatant 6ml;(9) add
Differential velocity adherent 1 hour in the culture dish of 10cm;(10) supernatant is transferred in the 60mm culture dish being coated with collagen, is simultaneously introduced
2.5ng/ml bFGF Inhibited differentiation, is incubated in 5%CO237 DEG C of incubator;(11) pass on (1 after 4-5 days:2);Receive simultaneously
The RNA of proliferation period (GM).(12) 0.25% trypsin are diluted 3 times with PBS;(13) take 1.5ml peptic cell, plus 1.5ml is complete
Full culture medium neutralization;(14) collect the idiophase RNA of (DM) with equal densities repopulating cell after breaking up 36 hours.(15) examine in real time
Survey expression in proliferation period and idiophase satellite cell for the miR-431.
The result of Fig. 3 shows:MiR-431 expression in the satellite cell of myostatin gene knock-out mice is higher than open country
Raw type mice, experimental result proves muscle mass negative regulation miR-431 further.
4. the muscle mass of vitro recombination processes C2C12 cell
First with 2 × 104Cell/cm2Repopulating cell changes division culture medium simultaneously with various dose (0,0.5 μ after 12 hours
G/mL, 1 μ g/mL, 1.5 μ g/mL) process C2C12 cell receive RNA (Fig. 4) after 24 hours;Then processed respectively with 1 μ g/mL dosage
The different time points of C2C12 cell (12h, 24h, 36h, 48h) receives RNA (Fig. 5) afterwards;Finally it is simultaneously introduced with 1 μ g/mL dosage
Follinstatin is jointly processed by C2C12 cell and receives RNA in 24 hours.Then detect respectively in various dose, different time and with
When add Follinstatin after miR-431 expression (Fig. 6).
The result of Fig. 4, Fig. 5 and Fig. 6 shows:Experiment in vitro is further characterized by the table of muscle mass negative regulation miR-431
Reach.
5. muscle mass lowers miR-431 expression by Mek/Erk signal path.
First with 2 × 104Cell/cm2Repopulating cell changes the inhibitor that division culture medium is simultaneously introduced Mek after 12 hours
After PD98059 half an hour, add the muscle mass of 1 μ g/mL dosage to process C2C12 cell after 24 hours, receive protein with
RNA.First detection muscle mass and PD98059 function, then detects the expression of miR-431.Western blot detects
The phosphorylation of Eek determines PD function.
The result of Fig. 7, Fig. 8 shows:Muscle chalone passes through Mek/Erk signal path negative regulation miR-431.
6. muscle mass lowers miR-431 expression by Ras/Raf signal path.
First with 2 × 104Cell/cm2Plantation DN-Ras C2C12 cell changes division culture medium after 12 hours and is simultaneously introduced
After the inhibitor PD98059 half an hour of Mek, the muscle mass of the dosage of 1 μ g/mL is added to process C2C12 cell 24 hours
Afterwards, protein and RNA are received.First detect muscle mass function, then detect the expression of miR-431.
The result of Fig. 9, Figure 10 shows:Muscle mass passes through the expression of Ras/Raf signal path negative regulation miR-431.
Conclusion:The above results show that internal and Vitro Experimental Results confirm the expression of muscle mass negative regulation miR-431,
Experiment in vitro is further characterized by the expression that muscle mass passes through Ras/Raf/Mek/Rrk signal path negative regulation miR-431.
Embodiment 2.miR-431 is enriched with and the differentiation with C2C12 cell and satellite cell in skeletal muscle tissue camber
Process expression increases.
For studying function in skeletal muscle for the miR-431, the express spectra of miR-431 is studied.Initially with
Northern trace has surveyed gene expression abundance in 8 each histoorgan of week old mice for the miR-431.In order to further determine that miR-
431 expression, have detected expression under C2C12 cell difference differentiation state for the miR-431, also have detected miR-431 simultaneously and exist
The expression of skeletal muscle satellite different differentiation phases.
MiR-431 is enriched with skeletal muscle tissue camber
Experimentation:From the mice of 8 week old, collect respectively lung, liver, heart, spleen, skeletal muscle, kidney, pancreas, small intestinal,
Brain and gastric tissue extract RNA first respectively and then carry out Northern Blot hybridization.Process is as follows:
(1) RNA extracts
Take fresh or frozen tissue material 50-100mg, liquid feeding nitrogen grind into powder in mortar, by a small amount of liquid of powder
Nitrogen transferss, in 15ml centrifuge tube, add 5ml Trizol homogenate, and room temperature stands 5 minutes.Plus 1ml chloroform (every milliliter of Trizol
Plus 0.2ml chloroform) concussion mixing, room temperature standing 10 minutes.12000g, 4 DEG C are centrifuged 15 minutes.By supernatant transfer to new from
Heart pipe adds 2.5ml isopropanol (every milliliter of Trizol adds 0.5ml isopropanol) to mix, and room temperature stands 10 minutes.12000g, 4 DEG C
Centrifugation 10 minutes.By precipitation 75% washing with alcohol of 5ml, it is dried, how much is dissolved in appropriate DEPC water depending on precipitation, is placed in
On ice.
(2) the denaturing formaldehyde gel electrophoresis of RNA
Prepare denaturing formaldehyde glue (1.2%):Weigh 1.2g agarose, plus 87ml DEPC H2O, heating and melting;To be cooled
During to 60 DEG C, add 10 × MOPS buffer of 10ml and 37% formaldehyde 3ml, mix;Plus fluorescent dye EB is to final concentration 0.5
μg/ml;Pour in ready agarose gel groove.
The preparation (10-15 μ g) of RNA sample:By 10 × MOPS buffer of 2.5 μ l, 4.4 μ l 37% formaldehyde, 12.5 μ l
Methanamide mixing;Add the RNA of 10-15 μ g, add DEPC H2O to 25 μ l;In 55 DEG C of heating in water bath 15min;Plus 5 μ l first
The sample-loading buffer of amide, point sample.
Denaturing formaldehyde gel electrophoresis:Dilution 10 × MOPS buffer, to 1 × MOPS, is poured in the electrophoresis tank of cleaning;To make
The gel got ready is placed in the electrophoresis tank of 1 × MOPS buffer, and prerunning is intact with testing equipment;Point sample;In 2v/cm voltage drop
Lower electrophoresis, moves to gel edges to bromjophenol blue and stops;Transferring film after photograph.
(3) transferring film:After electrophoresis terminates, gel is soaked in deionized water 30 minutes;By gel be placed in 10 × SSC (or
20 × SSC) soak 30min;After nylon membrane water-soaked, put into and in 10 × SSC (or 20 × SSC), soak 10min;By gel
Groove is buckled in as support in pallet, and lengthen bar 3MM filter paper bridge, spreads two-layer and glue size identical 3MM filter paper on support,
The gel handled well tips upside down on support, puts nylon membrane, then puts two-layer 3MM filter paper, puts the thick absorbent paper of a folded 7-8cm;
Pour 10 × SSC (or 20 × SSC) in pallet into, coated with preservative film, 500g weight in face pressure in absorbent paper, overnight (6 hours with
On).After transferring film terminates, after observing nucleic acid transfer completely under the uviol lamp in darkroom, control gel pencil is in nylon membrane subscript
Note loading wells and the position of molecular weight Marker or 28SrRNA, 18SrRNA.Finally clip nylon membrane with two-layer 3MM filter paper, purple
Nucleic acid on the fixing film of external crosslinking, also can put 2 hours of 80 DEG C of baking oven heat fixations.Film through fixing be placed in be dried place up to
Hybridization.
(4) probe labelling, purification and degeneration
Probe labelling:Make template mark probe with the PCR purified product or plasmid enzyme restriction recovery purifying product of purpose fragment,
Commonly use random primering at present, labelling reaction by specification carries out (Promega).
Probe Purification:The purpose of purified probes be in order to remove the free α that is not incorporated into-32P-dCTP, can pass through
Sephadex G-50 sieve chromatography by the free α being not incorporated into-32P-dCTP is separated with the nucleic acid fragment of labelling, collects eluting
Liquid i.e. containing the good nucleic acid fragment of labelling free α-32P-dCTP can be trapped in chromatography media.There is commercialization at present
Sephadex G-50 molecular sieve chromatography, centrifugation after loading can collect the nucleic acid fragment of labelling.
Probe degeneration:The good probe of purification boils degeneration in 5 minutes through 100 DEG C, is immediately placed in 2 minutes on ice, and centrifugation is a little.
Be stored in -20 DEG C standby.
(5) prehybridization and hybridization
Prehybridization:Nylon membrane is put into hybrid pipe, plus appropriate hybridization solution, 68 DEG C (being not added with the hybridization solution of Methanamide) or 42 DEG C
(plus hybridization solution of 50% Methanamide) prehybridization is more than half an hour.
Hybridization:Add the probe of degeneration in hybrid pipe, the amount adding probe is typically in every milliliter of hybridization solution 2 × 105--1
×106cpm.68 DEG C (being not added with the hybridization solution of Methanamide) or 42 DEG C (plus hybridization solution of 50% Methanamide) hybridize more than 8 hours.
(6) wash film
Film is washed in hybridization after terminating, remove the free probe of not hybridization, you can tabletting autography.
(7) tabletting autography
With preservative film, nylon membrane is wrapped, be fixed in X- light magazine, coated with X- mating plate, magazine be placed in -70 DEG C of refrigerators
Autoradiography, the general autography time is 3-5 days, and signal is weaker sometimes can autography more than one week.
(8) punching
After autography terminates, use developer solution and fixative solution punching in darkroom, the swimming lane having hybridization signal can be in X- mating plate
The band of a black in relevant position.
The result of Figure 11 shows:MiR-431 is enriched with skeletal muscle tissue camber;The result of Figure 12, Figure 13 shows:miR-
431 with skeleton satellite cell atomization expression increase.
Conclusion:The above results display miR-431 is enriched with simultaneously with myoblast differentiation process table in skeletal muscle camber
The amount of reaching increases this and points out miR-431 may participate in skeletal development also myoblastic atomization.
Embodiment 3.miR-431 promotes C2C12 cell differentiation.
In order to study function in skeletal muscle for the miR-431, C2C12 cell have detected the function of miR-431.First
First, the stably transfected cell line of overexpression miR-431 (60 times about) is constructed in C2C12 cell line, and using the mistake set up
The C2C12 cell line of expression miR-431 has carried out following functions detection.
First plant the cell of stable transfection mi-431 with certain density, after breeding 24 hours, change division culture medium, point
Change 24 hours, after 36 hours, detection differentiation early molecule labelling molecule myogenin (Myogenin) and late differentiation markers divide respectively
The expression of sub- MHC.Found by immunofluorescent staining, after breaking up 24 hours, overexpression miR-431 significantly increases into flesh
The quantity of plain positive cell, simultaneously the expression of myogenin dramatically increase in transcriptional level and protein level;After differentiation 36 hours,
Overexpression miR-431 significantly increases the quantity of MHC positive cell, and the expression of MHC is in transcriptional level and protein water simultaneously
Put down and dramatically increase.The above results show that overexpression miR-431 promotes C2C12 cell differentiation.
(1) build the cell line of stable transfection
First day
Before test, virus is placed in thaw on ice (slow viruss-GPF is comparison);In 35mm2Culture dish in add 1mL training
Foster base, prepares the centrifuge tube of 2 1.5mL;Peptic cell counts, and takes 1mL 2 × 105Individual cell is in the centrifuge tube of 1.5mL;Plus 20
μ L virus, in centrifuge tube, is gently mixed with pipette tips;Plus 3.2 μ L polybrene pipette tips gently mix;The cell mixing is dripped
It is added in 35mm2Culture dish in, put into incubator culture.
Second day
Cell is transferred to 60mm2Culture dish in.
3rd day
Cell is transferred to 10cm2Culture dish in, add final concentration of 1.5 μ g/mL puromycins;Transfect slow two days later
The cell almost all of virus-GPF matched group is died, and the cell of test group keeps good growth conditions, shows surely to turn cell
System successfully constructs.Detection expression efficiency, passes on conservation.
(2) Immunofluorescence test
Fixative:37% formalin is diluted to final concentration 2%-4% in PBS;Saturatingization liquid:0.5%
TritonX-100/PBS;Confining liquid:1-3%BSA/PBS;Mountant:Prepare 90% with the 2%DABCO/PBS preparing in advance
Glycerite.
Step:Immersion 2h in concentrated acid, drying at room temperature after cleaning are inserted in coverslip gradation.Coverslip through acid treatment is thrown
Enter in the Poly-L-Lysine Solution of ten times of dilutions, room temperature is taken out after placing 5min and 1h is dried in 60 DEG C.With front, coverslip is soaked
At least 30min in 75% ethanol.Transfection or carry out the cell of respective handling with PBS 3 times, drains away the water, with fixative
Room temperature fixes 10min;PBS rinses 3 times.Under room temperature, cell is permeabilized 3 × 10min with 0.5%Triton-X100/PBS.With
1-3%BSA/PBS closing cell, 37 DEG C of 30min;Parafilm film add 40 μ L dilute by a certain percentage with PBS-T (logical
Normal 1:50) one resists, and is sealed in wet box, 37 DEG C of 1h.Under room temperature, 0.5%Triton-X100/PBS rinses 3 × 10min.?
40 μ L are added to dilute (usual 1 by a certain percentage with PBS-T on Parafilm film:80) two resist, and are sealed in 37 DEG C in wet box,
1h.Under room temperature, 0.5%Triton-X100/PBS rinses 3 × 10min.1 is added when rinsing for second:10000DAPI(DAPI/
0.5%Triton);Deionized water rinsing is desalted.10 μ L mountant are taken to drop on microscope slide.Use fluorescence microscope or laser at once
Confocal microscopy is simultaneously taken a picture.
Conclusion:Figure 14 to Figure 19 result shows that miR-431 can promote the differentiation of C2C12 cell.
Embodiment 4.miR-431 promotes the process of Skeletal muscle injury regeneration.
Experimentation
MiR-431 transgenic mice constructed by the model animal of Nanjing, wild-type mice three littermate control in test.For true
Determine function in skeletal injury regeneration for the miR-431, construct miR-431 transgenic mice CTX damage model, mice right lower limb shin
50 μ L × 10 μM CTX are penetrated in intramuscular injection before bone, and left lower limb injection compares just as the PBS of volume, after injury 1,3, collect respectively within 7 days
Skeletal muscle tissue, dyes process and the form observing anathrepsis by HE.By immunofluorescence dyeing and western blot skill
Art detects the expression of Pax7 or MyoD.Study the function of skeletal muscle satellite cell in vivo, one of common method is by little
Murine skeletal muscle tissue injection CTX sets up skeletal muscle tissue injury regeneration model.
It is inflammatory reaction first after Skeletal muscle injury, substantial amounts of inflammatory factor is released, and is in the skeletal muscle of quiescent condition
Satellite cell is activated, and a large amount of propagation of satellite cell of activation is merged with the muscle fiber damaging subsequently into differentiation program, utilizes
MyoD positive cell number come to assess profit activation satellite cell number.After skeletal muscle tissue damages 3 days, satellite cell increases in a large number
Grow, the process of satellite cell propagation can be assessed by detecting the number of satellite cell;Damage 7 days after formed a large amount of cores in
The muscle fiber of the new formation of centre, by comparing the sectional area size of the muscle fiber horizontal stroke in central new formation for the core and the dynamic of eMHC
Change and to assess the process of differentiation.
(1) paraffin embedding and haematoxylin and Yihong (HE) dyeing:The tibialis anterior taking off is fixed on 10% formalin
(formalin 1:10 are dissolved in PBS) in 24-48 hour;Soak each 1 hour through 70%, 80%, 95%, 100% ethanol after fixation
To being dehydrated completely;It is transferred to dimethylbenzene transparent each half an hour twice after dehydration;In the saturating wax of 50-60 DEG C of temperature and embedding (Leica
The full-automatic embedding machine of EG1150);Finishing wax stone sample, section 3-4 micron (Leica RM2255 fully-automatic rotation microtome);Will
Section separates, and puts into exhibition piece (Leica HI1220 spreads out piece machine) bak stay in 40 DEG C of tepidarium and, to microscope slide, is scalding
Upper 60 DEG C of plate (Leica HI1210 bakes piece machine) is dried;Tissue slice is placed in dimethylbenzene and soaks 10 minutes, after changing dimethylbenzene
Soak 10 minutes again.Soak 5 minutes in dehydrated alcohol;Soak 5 minutes in 95% ethanol;Soak 5 minutes in 70% ethanol;Finally
Enter distilled water immersion 2 minutes;Entered the section after distilled water and put into dyeing 5 minutes in hematoxylin aqueous solution.Sour water and ammonia
Middle color separation, each several seconds.Flowing water enters distilled water a moment after rinsing 5 minutes.Enter to be dehydrated in 70% and 90% ethanol each 5 minutes.Enter
Ethanol eosin stains liquid dyes 23 minutes.It is dehydrated through absolute alcohol after dyeing, then makes section transparent through dimethylbenzene, use neutral gum
Mounting.
(2) photograph and data statisticss:With just putting photo under microscope (Olypums BX 53) × 20 times of mirrors, manual count
In damage field unit area, the new core being formed is in central muscle fiber number.
(3) frozen section preparation:The fresh tibialis anterior muscular tissue taken off is put into and fills embedding medium (oriental cherry, 4583)
Mould in, by mould immersion liquid nitrogen so that it is solidified, with full-automatic slicing machine (Leica CM3050), embedded block is cut into slices to 10
Micron is thick, and thin section is labelled on microscope slide, puts in -70 DEG C of refrigerators and preserves.
(4) Pax7 immunofluorescence dyeing:Frozen section is taken out from -70 DEG C of refrigerators placement room temperature to dry;In 4% poly
20 minutes are fixed in formaldehyde (4 grams of paraformaldehydes (Sigma) are dissolved in 100 milliliters of PBS);Cleaning 3 times in PBS, 5 minutes every time;
- 20 DEG C of methanol permeates 6 minutes;Cleaning 3 times in PBS, 5 minutes every time;(0.294 gram of 0.01M sodium citrate buffer solution of configuration
Two citric acid monohydrate trisodiums are dissolved in 100 milliliters of PBS, regulation pH value to 6.0), it is preheated to 90 DEG C;Fructus Citri Limoniae by section immersion heat
Sour sodium buffer, 80 DEG C are incubated 5 minutes, renew the sodium citrate buffer solution of preheating, 80 DEG C are incubated 5 minutes again;Room temperature cooling is cut
Piece, cleaning 3 times in PBS, 5 minutes every time;Room temperature envelope in 4%BSA (0.4 gram of BSA (Jackson) is dissolved in 10 milliliters of PBS)
Close 2-3 hour;Clean 2 minutes in PBS;Dilution FAB (Jackson) 1:In 100 to PBS, in FAB, room temperature is closed 30 minutes;
Clean 2 minutes in PBS;With Pax7 antibody (DSHB, 1:20 are dissolved in 4%BSA) in 4 DEG C of overnight incubation;Clean 2 minutes in PBS;
3 times are washed in 0.1%BSA, 10 minutes every time;In GaM-Biotin (Jackson, 1:1000 are dissolved in 4%BSA) incubated at room
45 minutes;Clean 2 minutes in PBS;3 times are washed in 0.1%BSA, 10 minutes every time;In Cy3-Strep (Jackson, 1:1000
It is dissolved in 4%BSA) incubated at room 30 minutes;Cleaning 3 times in PBS, 10 minutes every time;DAPI contaminates core, cleans 10 minutes in PBS;
Mounting is taken a picture.
(5) MyoD immunofluorescence dyeing:Frozen section is taken out from -70 DEG C of refrigerators placement room temperature to dry;In 4% poly
20 minutes are fixed in formaldehyde;Cleaning 3 times in PBS, 5 minutes every time;- 20 DEG C of methanol permeates 6 minutes;Clean 3 times in PBS,
5 minutes every time;5%BSA room temperature is closed 2 hours;With MyoD antibody (Santa Cruz, 1:50 are dissolved in 5%BSA) incubate in 4 DEG C
Educate overnight;Cleaning 3 times in PBS, 10 minutes every time;Two anti-incubated at room 1 hour;Cleaning 3 times in PBS, 10 minutes every time;DAPI
Dye core, cleans 10 minutes in PBS;Mounting is taken a picture.
Conclusion:In Figure 20-21 display miR-431 transgenic mice, injury regeneration process is significantly faster than wild-type mice.Figure
22-24 display miR-431 transgenic mice has more MyoD positive cells after damaging 1 day, Figure 25-27 display miR-431 turns
DNA murine has the double positive cell of more Pax7+/MyoD+ after damaging 3 days.Figure 28-29 display miR-431 transgenic is little
The differentiation of Mus centre halfback astrocyte is faster than wild-type mice.The activation that above-mentioned data display miR-431 passes through to accelerate satellite cell increases
Grow and break up and to accelerate the injury regeneration process of satellite cell.
Embodiment 5.miR-431 promotes skeletal muscle satellite differentiation.
Experimentation
In order to confirm miR-431 promote skeletal muscle satellite cell differentiation function, separate miR-431 transgenic mice and
The skeletal muscle satellite cell of wild-type mice, is planted in 12 orifice plates with identical density, after differentiation 36, is broken up by dyeing
The expression of marker gene MCH positive cell and detection MHC mRNA has also separated single myofibrillar isolated culture simultaneously, point
Do not contaminate different types of satellite cell respectively with Pax7, MyoD, DAPI.
The single muscle fiber of separating mouse skeletal muscle
Preparation:0.2% collagenase I is dissolved in plasma-free DMEM medium;Cleaning mixture:Serum DMEM culture medium, plus 2%
Dual anti-;Muscle fiber proliferated culture medium:DMEM cultivates, plus 20% hyclone (FBS), that 1% chick embryo extract adds 1% is dual anti-;With
Hyclone (FBS) is coated culture dish.
Test procedure
Take the male Mus 1 of 6-10 week old, disconnected neck is put to death, and sprays alcohol disinfecting.Tear skin from direction of toe of last, do not hinder as far as possible
To tibialis anterior, first use dissecting needle in the tendon of direction of toe of last separation tibialis anterior (TA) and extensor digitorum longus (EDL), determine tibia
The position of front flesh (TA), so as to separate with extensor digitorum longus (EDL), then cuts off the tendon of quadriceps femoris, carefully at knee joint
Separate the upper end tendon finding extensor digitorum longus (EDL), then cut off with scalpel, in toe end gently by complete extensor digitorum longus
(EDL) take away.(this step is whole Success in Experiment whether key);Complete extensor digitorum longus (EDL) are put into equipped with 2ml
40-60 minute is digested at 37 DEG C, until seeing that the fiber having hairline sample stops digestion in 0.2% collagenase I Digestive system;Aobvious
Under micro mirror, muscle fiber single in Digestive system is transferred in cleaning mixture one by one with 10 μ L pipette tips, after single muscle fiber washs 2 times
Transfer in muscle fiber proliferated culture medium, cultivate 72 hours;By immunofluorescence dyeing detect Pax7 or MyoD expression thus
Labelling satellite cell, the quantity of satellite cell on the single muscle fiber of manual count.
Conclusion
As shown in Figure 30-32, miR-431 can promote the differentiation of skeletal muscle satellite cell, miR-431 as shown in Figure 33-34
The satellite cell being in the idiophase in transgenic mice is significantly more than wild-type mice.As above experiment proves that miR-431 promotes skeleton
The differentiation of muscle satellite cell.
Embodiment 6.miR-431 can significantly improve the Pathophysiology phenotype of mdx mice
Experimentation
Mdx mice is the model mice of Du Shi muscular dystrophy disease.It is because the dystrophin gene of Xp21 is dashed forward
Become and cause dystrophin on skeletal muscle sarolemma to lack wholly or in part and cause.Dystrophin connect cell interior with
The stability aspect of external structure, signal transduction and cell membrane plays important function.In Mdx mouse disease model, due to
The disappearance of Dystroglycan leads to the breakage of muscle cell membrane structure, and intracellular matter such as creatine kinase leaks, and the fragility of muscle increases
Plus, contracts last ability reduces.The damage of myocyte can activate satellite and carry out injury repairing, form core in central new granulation promoting
Fiber.Due to the presence of dystrophin mutant gene, the new sarcolemma being formed is damaged quickly, and muscle fiber is impaired, stimulates
Satellite cell carries out injury repairing again.Therefore, Mdx mice is constantly in the damaged circulation with injury repairing of muscle fiber.
The result of preceding embodiment shows that miR-431 can accelerate Skeletal muscle injury again by promoting the differentiation of satellite cell
Raw process, then whether miR-431 can alleviate the Pathology of Mdx disease model mice to a certain extent.By detection
In myocyte, creatine kinase leaks concentration in serum and azovan blue penetrates into Skeletal Muscle Cell through damaged sarcolemma
In the degree of injury to judge Mdx Muscle Tissue for the situation.Pass through run test and the in vitro skeletal muscle of mice simultaneously
The test of fibre tension is assessing Mdx mice skeletal function.
For determining whether miR-431 can be in the Pathology to a certain degree improving Mdx disease model mice and physiology work(
Can, first Mdx mice is copulationed with miR-431 transgenic mice, the male Mdx obtaining:MiR-431 is used with Mdx mice
In experiment, B6 mice normal control mice, thus detecting whether miR-431 can improve the Pathology of Mdx mice.
(1) in serum CK level detection
General 2-4 hour detection CK value after mice is run;
Pluck eyeball and take blood;
4 DEG C standing 1-2 hours, 12000rpm be centrifuged 10 minutes by serum transfers in new EP pipe;
Configuration reactant liquor:Every hole adds 10 μ L substrates, the enzyme of the reaction buffer of 100 μ L and 1 μ L;
110 μ L are added in enzyme mark version:100μL H2O and 10 μ L standard substance (Calibrator) and 100 μ L reactant liquors and 10 μ
The 37 DEG C of incubations of L blood utilize the light absorption value that microplate reader reads 340nm for 20 minutes, then proceed to be incubated the suction reading 340nm for 20 minutes
Light value, then calculates CK value using formula once.
(2) mice is run and tests
Mdx:MiR-431, Mdx and B6 mice under identical rearing conditions, run in flat board by running test experiments
(Exer3/6Columbus Instruments) is carried out on machine.Experiment is divided into training and official testing, using 20 degree during experiment
Descending inclination angle.Train before official testing twice, carry out every other day.Running condition setting is as follows:10 ms/min of starting velocity,
After three minutes, accelerate to 20 ms/min with 1 m/min of speed, then go to mice fatigue always with 20 ms/min of speed
Till, typically setting NOS (mice is parked in the number of times on stimulator) is 100.After training, start official testing, altogether survey
Examination 4 times, is to carry out every other day every time.
(3) the in vitro pull test of skeletal muscle
Configuration electrolyte is adjusted to PH=7.0, adds in four chamber water baths, general tissue temperature is in 37 ° of Mdx skeletal muscle
Adjust temperature and be 25 °, wherein pass through 95% oxygen -5% carbon dioxide, more than half an hour.
Separate complete extensor digitorum longus (EDL) according to the method separating in single muscle fiber, skeletal muscle tissue is detached complete
Whether whole very big on testing last result impact.Completely detached EDL is fixed between another electrode (the step in electricity
Operate in solution liquid, action is as far as possible fast).First balance 10 minutes in the electrolytic solution.
The condition of tic tension force detection:Using 10V voltage, the persistent period is the square wave of 0.3ms.It is repeated 3 times, every septum secundum 10
Second is once.
The condition of tetanic tension detection:Using 10V voltage, the persistent period is a string ripple of 200ms, and wherein each is lasting
Time is the square wave of 0.3ms.It is repeated 3 times, every minor tick 3 minutes.
Conclusion
miR-431::Mdx mice muscle group azovan blue is contaminated area and is significantly reduced (Figure 35 A and 35B);As representative, only
Show the picture (Figure 36) of azovan blue dip-dye muscle injury in tibialis anterior, Figure 37 shows miR-431::Mdx mice group blood
Middle clearly creatine kinase level substantially reduces compared with matched group.Figure 38 shows miR-431::Mdx mice group running achievement is better than comparison
Group.Figure 39 and 40 display miR-431::Mdx mice group synthetic data Mdx mouse muscle pulling force is better than matched group.
Summary miR-431 overexpression miR-431 in mankind DMD disease model Mdx mice can significantly improve
The Pathology of Mdx mice and physiological function.
List of references
1.Lancaster,G.I.and M.A.Febbraio,Skeletal muscle:not simply an organ
for locomotion and energy storage.J Physiol,2009.587(Pt 3):p.509-10.
2.Mauro,A.,Satellite cell of skeletal muscle fibers.J Biophys Biochem
Cytol,1961.9:p.493-5.
3.Grounds,M.D.and Z.Yablonka-Reuveni,Molecular and cell biology of
skeletal muscle regeneration.Mol Cell Biol Hum Dis Ser,1993.3:p.210-56.
4.Kuang,S.,M.A.Gillespie,and M.A.Rudnicki,Niche regulation of muscle
satellite cell self-renewal and differentiation.Cell Stem Cell,2008.2(1):
p.22-31.
5.Lepper,C.,T.A.Partridge,and C.M.Fan,An absolute requirement for
Pax7-positive satellite cells in acute injury-induced skeletal muscle
regeneration.Development,2011.138(17):p.3639-46.
6.McCarthy,J.J.,et al.,Effective fiber hypertrophy in satellite cell-
depleted skeletal muscle.Development,2011.138(17):p.3657-66.
7.Murphy,M.M.,et al.,Satellite cells,connective tissue fibroblasts
and their interactions are crucial for muscle regeneration.Development,
2011.138(17):p.3625-37.
8.Sambasivan,R.,et al.,Pax7-expressing satellite cells are
indispensable for adult skeletal muscle regeneration.Development,2011.138
(17):p.3647-56.
9.Naguibneva,I.,et al.,The microRNA miR-181 targets the homeobox
protein Hox-A11 during mammalian myoblast differentiation.Nat Cell Biol,
2006.8(3):p.278-84.
10.Chen,Y.,et al.,MiR-351 transiently increases during muscle
regeneration and promotes progenitor cell proliferation and survival upon
differentiation.Physiol Genomics,2012.44(21):p.1042-51.
11.Liu,N.,et al.,microRNA-206 promotes skeletal muscle regeneration
and delays progression of Duchenne muscular dystrophy in mice.J Clin Invest,
2012.122(6):p.2054-65.
12.Maciotta,S.,et al.,Hmgb3 is regulated by microRNA-206 during
muscle regeneration.PLoS One,2012.7(8):p.e43464.
13.Chen,J.F.,et al.,microRNA-1 and microRNA-206 regulate skeletal
muscle satellite cell proliferation and differentiation by repressing Pax7.J
Cell Biol,2010.190(5):p.867-79.
14.Dey,B.K.,et al.,miR-26a is required for skeletal muscle
differentiation and regeneration in mice.Genes Dev,2012.26(19):p.2180-91.
15.Ge,Y.,Y.Sun,and J.Chen,IGF-II is regulated by microRNA-125b in
skeletal myogenesis.J Cell Biol,2011.192(1):p.69-81.
16.Yin,H.,et al.,MicroRNA-133 controls brown adipose determination in
skeletal muscle satellite cells by targeting Prdm16.Cell Metab,2013.17(2):
p.210-24.
17.McPherron,A.C.and S.J.Lee,Double muscling in cattle due to
mutations in the myostatin gene.Proc Natl Acad Sci U S A,1997.94(23):p.12457-
61.
18.Kambadur,R.,et al.,Mutations in myostatin(GDF8)in double-muscled
Belgian Blue and Piedmontese cattle.Genome Res,1997.7(9):p.910-6.
19.Grobet,L.,et al.,A deletion in the bovine myostatin gene causes
the double-muscled phenotype in cattle.Nat Genet,1997.17(1):p.71-4.
20.Mosher,D.S.,et al.,A mutation in the myostatin gene increases
muscle mass and enhances racing performance in heterozygote dogs.PLoS Genet,
2007.3(5):p.e79.
21.Clop,A.,et al.,A mutation creating a potential illegitimate
microRNA target site in the myostatin gene affects muscularity in sheep.Nat
Genet,2006.38(7):p.813-8.
22.Schuelke,M.,et al.,Myostatin mutation associated with gross muscle
hypertrophy in a child.N Engl J Med,2004.350(26):p.2682-8.
23.Partridge,T.A.,et al.,Conversion of mdx myofibres from dystrophin-
negative to-positive by injection of normal myoblasts.Nature,1989.337(6203):
p.176-9.
Claims (9)
- Purposes in the medicine of preparation treatment muscle disease for the miR-431 shown in 1.SEQ ID No.1, wherein said muscle disease Disease is selected from muscle injury and muscular dystrophy.
- 2. purposes according to claim 1, described treatment refers to selected from following one or more:Promote myoblastic Differentiation, promotion Skeletal muscle injury regenerate, improve pathology and physiological phenotype.
- 3. purposes according to claim 2, the myoblastic differentiation of described promotion refers to improve myogenin and/or flesh ball egg The expression of Bai Chonglian.
- 4. purposes according to claim 2, described promotion Skeletal muscle injury regeneration refers to promote skeletal muscle satellite cell Activation, propagation and differentiation.
- 5. purposes according to claim 2, described improves pathology and physiological phenotype is selected from:Reduce serum creatine kinase water Flat, improvement fatigue, raising muscle fiber tension force and combinations thereof.
- 6. purposes according to claim 1, wherein said muscle injury is acute muscle injury.
- 7. purposes according to claim 1, wherein said muscular dystrophy is selected from:Duchenne/Becker type myotrophy Bad, face shoulder-upper arm type muscular dystrophy, limb-girdle type muscular dystrophy, quadriceps femoris type muscular dystrophy, distal type myotrophy are not Good, ocular myopathy type muscular dystrophy and eye muscle-pharynx flesh type muscular dystrophy.
- 8. purposes according to claim 7, wherein said muscular dystrophy is for Duchenne/Becker type myotrophy not Good.
- MiR-431 shown in 9.SEQ ID No.1 promotes the use in the medicine of muscle stem cell activation, propagation and differentiation in preparation On the way.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410496029.3A CN104306988B (en) | 2014-09-25 | 2014-09-25 | Uses of miR-431 in preparation of muscular disease treatment medicines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410496029.3A CN104306988B (en) | 2014-09-25 | 2014-09-25 | Uses of miR-431 in preparation of muscular disease treatment medicines |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104306988A CN104306988A (en) | 2015-01-28 |
CN104306988B true CN104306988B (en) | 2017-02-15 |
Family
ID=52362391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410496029.3A Active CN104306988B (en) | 2014-09-25 | 2014-09-25 | Uses of miR-431 in preparation of muscular disease treatment medicines |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104306988B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016178519A1 (en) * | 2015-05-06 | 2016-11-10 | 한국생명공학연구원 | Composition for inhibiting muscle aging or treating muscle aging related diseases |
CN105688227B (en) * | 2016-02-02 | 2020-06-19 | 中国医学科学院基础医学研究所 | Application of miR-127 in preparation of medicine for treating muscle diseases |
CN112041443A (en) * | 2018-01-09 | 2020-12-04 | 韩国生命工学研究院 | Pharmaceutical composition for preventing or treating muscle diseases or cachexia comprising miRNA or variant thereof located in the dkk 1-Dio3 cluster as active ingredient |
CN108728437A (en) * | 2018-05-25 | 2018-11-02 | 中国人民解放军陆军军医大学 | Promote oligonucleotides, drug and the application of Skeletal muscle injury reparation |
EP3755213B1 (en) * | 2019-04-30 | 2023-09-13 | Alis Pharma Ltd. | Uses of fetal tissue extract |
CN114075541A (en) * | 2020-08-11 | 2022-02-22 | 中国科学院分子细胞科学卓越创新中心 | Induction of expansion of muscle stem cells |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5814505B2 (en) * | 2006-04-03 | 2015-11-17 | ロシュ・イノベーション・センター・コペンハーゲン・アクティーゼルスカブRoche Innovation Center Copenhagen A/S | Pharmaceutical composition comprising antimiRNA antisense oligonucleotide |
WO2011029903A1 (en) * | 2009-09-10 | 2011-03-17 | Flemming Velin | Method for the preparation of micro-rna and its therapeutic application |
CN102212517B (en) * | 2010-04-07 | 2015-01-07 | 中国科学院动物研究所 | Key genes, microRNAs and other non-coding RNAs or combination thereof used for identifying or regulating cell pluripotency |
-
2014
- 2014-09-25 CN CN201410496029.3A patent/CN104306988B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104306988A (en) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104306988B (en) | Uses of miR-431 in preparation of muscular disease treatment medicines | |
JP5645816B2 (en) | Pharmaceutical composition comprising core factor related to proliferation and differentiation of central nerve cell | |
BR112020018602A2 (en) | TRANSIENT CELL REPROGRAMMING FOR REVERSING CELLULAR AGING | |
Chai et al. | Ff1b is required for the development of steroidogenic component of the zebrafish interrenal organ | |
CN102105789A (en) | Brown adipocyte progenitors in human skeletal muscle | |
Chen et al. | Inhibition of MEF2A prevents hyperglycemia-induced extracellular matrix accumulation by blocking Akt and TGF-β1/Smad activation in cardiac fibroblasts | |
Yan et al. | CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells | |
EP3835413A1 (en) | Method and composition for promoting cell growth and tissue repair | |
CN106480037A (en) | A kind of long non-coding RNA and the application in diagnosis preeclampsia and target drug treatment is prepared | |
Youm et al. | NADPH oxidase 4 contributes to myoblast fusion and skeletal muscle regeneration | |
CN104083761A (en) | Application of microRNA-101 (micro-ribonucleic acid-101) inhibitor in preparing medicaments for preventing or treating osteoarthritis | |
CN102482337A (en) | Muteins of the pyrroline-5-carboxylate reductase 1 | |
CN105457028B (en) | The stress sensitivity microRNA of regulating and controlling effect is played in bon e formation | |
JPWO2019178296A5 (en) | ||
Tao et al. | Small extracellular vesicles with LncRNA H19 “overload”: YAP regulation as a tendon repair therapeutic tactic | |
Garcia-Parra et al. | Murine muscle engineered from dermal precursors: an in vitro model for skeletal muscle generation, degeneration, and fatty infiltration | |
Yin et al. | Dynamics of cardiomyocyte and muscle stem cell proliferation in pig | |
CN104606230B (en) | Application of the fat mesenchymal stem cell in terms of lipid-loweringing | |
EP3834834A1 (en) | Drug used for treating tissue necrosis or for improving cardiac function | |
CN105688227B (en) | Application of miR-127 in preparation of medicine for treating muscle diseases | |
CN110157708A (en) | It is a kind of inhibit human glioma targeting linc01023 gene inhibitor and its application | |
CN109939222B (en) | Medical application of CREG protein for promoting skeletal muscle regeneration | |
CN106148341A (en) | The inhibitor of a kind of lncRNA-MSR and application thereof | |
CN111214660B (en) | Application of PAX4 gene expression inhibitor in preparation of medicine for inhibiting fibrosis | |
Yuan et al. | miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |